US FDA approves Nuvation Bio's lung cancer therapy-February 2024-www.financetom.com

US FDA approves Nuvation Bio's lung cancer therapy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Nuvation Bio's lung cancer therapy

Jun 11, 2025 10:38 AM

June 11 (Reuters) - The U.S. Food and Drug

Administration said on Wednesday it has approved Nuvation Bio's ( NUVB )

therapy for patients with a type of lung cancer.

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： Toll Brothers Insider Sold Shares Worth $463,730, According to a Recent SEC Filing Next page： Rbc Bearings Insider Sold Shares Worth $387,803, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Toll Brothers Insider Sold Shares Worth $463,730, According to a Recent SEC Filing

Jun 13, 2024

04:22 PM EDT, 06/13/2024 (MT Newswires) -- Martin P. Connor, Chief Financial Officer, on June 12, 2024, sold 3,806 shares in Toll Brothers ( TOL ) for $463,730. Following the Form 4 filing with the SEC, Connor has control over a total of 24,721 shares of the company, with 24,721 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/794170/000112760224018559/xslF345X03/form4.xml Price: 120.10, Change: -0.68,...

Rbc Bearings Insider Sold Shares Worth $387,803, According to a Recent SEC Filing

Jun 13, 2024

04:22 PM EDT, 06/13/2024 (MT Newswires) -- Steven H. Kaplan, Director, on June 11, 2024, sold 1,400 shares in Rbc Bearings ( RBC ) for $387,803. Following the Form 4 filing with the SEC, Kaplan has control over a total of 2,593 shares of the company, with 2,593 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1324948/000159396824000850/xslF345X03/primary_01.xml Price: 271.61, Change: -3.25, Percent Change:...

Halozyme Therapeutics Insider Sold Shares Worth $1,006,300, According to a Recent SEC Filing

Jun 13, 2024

04:23 PM EDT, 06/13/2024 (MT Newswires) -- Matthew L. Posard, Director, on June 11, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $1,006,300. Following the Form 4 filing with the SEC, Posard has control over a total of 99,755 shares of the company, with 99,755 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000141588924016672/xslF345X03/form4-06132024_080638.xml ...

Rezolute Starts Equity Offering -- Shares Fall After Hours

Jun 13, 2024

04:22 PM EDT, 06/13/2024 (MT Newswires) -- Rezolute ( RZLT ) said late Thursday it's starting an underwritten public offering of shares, or pre-funded warrants to buy shares. Underwriters will be given an option for a 30-day period to buy up to an additional 15% shares, plus the shares underlying the warrants, the company said. The offering is subject to...